In a last-minute move, the Biden administration aims to allow Medicare to cover weight-loss drugs like Wegovy and Zepbound, sparking a rise in shares for Novo Nordisk and Eli Lilly.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Lilly Stock Jumps on Zepbound Medicare Hopes. Curb Your Enthusiasm.
